Meeder Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3
| Closed | – | – | 848 |
|
|
2022
Q3 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 2133 |
|
|
2022
Q2 | $0 | Sell |
2
-16
| -89% | – | ﹤0.01% | 2167 |
|
|
2022
Q1 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 2136 |
|
|
2021
Q4 | – | Sell |
-1,392
| Closed | -$45K | – | 1190 |
|
|
2021
Q3 | $45K | Buy |
1,392
+1,369
| +5,952% | +$44.3K | ﹤0.01% | 1120 |
|
|
2021
Q2 | $1K | Hold |
23
| – | – | ﹤0.01% | 2302 |
|
|
2021
Q1 | $1K | Sell |
23
-4
| -15% | -$174 | ﹤0.01% | 2170 |
|
|
2020
Q4 | $1K | Buy |
27
+2
| +8% | +$74 | ﹤0.01% | 1587 |
|
|
2020
Q3 | $1K | Buy |
25
+23
| +1,150% | +$920 | ﹤0.01% | 1919 |
|
|
2020
Q2 | $0 | Sell |
2
-29
| -94% | – | ﹤0.01% | 2037 |
|
|
2020
Q1 | $1K | Sell |
31
-1,969
| -98% | -$63.5K | ﹤0.01% | 2159 |
|
|
2019
Q4 | $125K | Buy |
2,000
+1,980
| +9,900% | +$124K | 0.01% | 732 |
|
|
2019
Q3 | $1K | Sell |
20
-2,548
| -99% | -$127K | ﹤0.01% | 2036 |
|
|
2019
Q2 | $211K | Buy |
+2,568
| New | +$211K | 0.01% | 566 |
|
|
2018
Q4 | – | Sell |
-7
| Closed | – | – | 1703 |
|
|
2018
Q3 | $0 | Sell |
7
-155
| -96% | – | ﹤0.01% | 1527 |
|
|
2018
Q2 | $10.8K | Sell |
162
-3
| -2% | -$200 | ﹤0.01% | 1110 |
|
|
2018
Q1 | $10K | Sell |
165
-62
| -27% | -$3.76K | ﹤0.01% | 1054 |
|
|
2017
Q4 | $14K | Buy |
227
+200
| +741% | +$12.3K | ﹤0.01% | 1040 |
|
|
2017
Q3 | $1K | Hold |
27
| – | – | ﹤0.01% | 1532 |
|
|
2017
Q2 | $1K | Buy |
+27
| New | +$1K | ﹤0.01% | 1493 |
|